FY26-27 Adult Covid-19 Vaccines

This document is a Standard Form 1449,

The Centers for Disease Control and Prevention (CDC) is issuing an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract for the procurement of COVID-19 adult vaccines for the 2026-2027 season, with an option to purchase for the 2025-2026 season. The contract, with a maximum value of $892,363,500, aims to provide vaccines for state and local health departments to serve at-risk populations. Orders will be placed through the Vaccine Tracking System (VTrckS) based on clinical appropriateness, advisory committee recommendations, and funding availability. Key contract clauses cover shelf life, packaging, delivery within 15 working days, product licensure, and adherence to Federal Ceiling Prices. The contract also details invoicing, payment methods, return privileges for non-conforming vaccines, restrictions on use, federal excise tax credits, and reporting requirements for delinquent deliveries and biological surveillance data.

The Authorized Distributor of Record (ADR) Agreement establishes a relationship between a manufacturer/supplier and the Centers for Disease Control and Prevention (CDC), designating the CDC as an ADR in compliance with the Prescription Drug Marketing Act (PDMA) of 1988 and 21 CFR Part 203. The CDC agrees to adhere to all applicable state and federal laws to maintain this status. The agreement requires a list of specific products the CDC is authorized to distribute, identified by pharmaceutical/vaccine name, dosage, strength, and NDC number, or a statement indicating authorization for the entire product line. This agreement is valid from the date of dual execution until terminated by either party with ninety days' written notice. It does not alter any pre-existing or future distribution agreements and solely confers the right to designate the CDC as an ADR, not acting as a sales or other type of agreement beyond representing an “ongoing relationship” as defined in 21 CFR Part 203.3(u).

The document, titled "D-2: List of Products," is a concise inventory that enumerates specific products by Item Number, Product/Brand Name, and National Drug Code (NDC). The sole product listed across all three entries is "Vaccine," each accompanied by a unique NDC. This type of document is typical in government solicitations, such as RFPs or grant applications, where it serves to provide a clear and organized list of items pertinent to a proposed project or procurement. In the context of federal or state/local RFPs, such a list could be part of a proposal for the supply of medical products, a grant application for a public health initiative requiring vaccines, or a response to a tender for pharmaceutical goods. The document's primary purpose is to clearly identify and categorize the vaccines, likely for inventory, procurement, or regulatory compliance purposes within a government-related project.